159 related articles for article (PubMed ID: 22692862)
41. Cutaneous adverse effects of ketoprofen for topical use: clinical patterns and costs.
Noize P; Bénard-Laribière A; Aulois-Griot M; Moore N; Miremont-Salamé G; Haramburu F
Am J Clin Dermatol; 2010; 11(2):131-6. PubMed ID: 20141234
[TBL] [Abstract][Full Text] [Related]
42. The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy.
Carnovale C; Brusadelli T; Zuccotti G; Beretta S; Sullo MG; Capuano A; Rossi F; Moschini M; Mugelli A; Vannacci A; Laterza M; Clementi E; Radice S;
Expert Opin Drug Saf; 2014 Sep; 13 Suppl 1():S1-8. PubMed ID: 25171154
[TBL] [Abstract][Full Text] [Related]
43. [Systematic analysis on clinical safety of Shuxuetong injection].
Guo XF; Wen ZH; Xie YM; Liu SN; Li ZY; Chen DC
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2782-5. PubMed ID: 23285933
[TBL] [Abstract][Full Text] [Related]
44. Adverse drug reactions in children in Camagüey Province, Cuba.
Arencibia ZB; Sotomayor DN; Mollinedo NC; Choonara I; Manzano EF; Leyva AL
Arch Dis Child; 2010 Jun; 95(6):474-7. PubMed ID: 20501541
[TBL] [Abstract][Full Text] [Related]
45. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
Shalviri G; Mohammad K; Majdzadeh R; Gholami K
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
[TBL] [Abstract][Full Text] [Related]
46. Under-reporting of serious adverse drug reactions in Sweden.
Bäckström M; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
[TBL] [Abstract][Full Text] [Related]
47. Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016.
Oreagba IA; Oshikoya KA; Ogar C; Adefurin AO; Ibrahim A; Awodele O; Oni Y
Pharmacol Res Perspect; 2017 Apr; 5(2):e00297. PubMed ID: 28357123
[TBL] [Abstract][Full Text] [Related]
48. Injection Site Reactions Before and After Intramuscular Injection Technique Revision: A Postmarketing Analysis of NALDEBAIN® From 2017 to 2022.
Man KM; Lee SO; Lu CH; Wong CS; Sun WZ
Asian J Anesthesiol; 2023 Mar; 61(1):14-20. PubMed ID: 37160663
[TBL] [Abstract][Full Text] [Related]
49. Risk in homeopathy: Classification of adverse events and homeopathic aggravations--A cross sectional study among Norwegian homeopath patients.
Stub T; Kristoffersen AE; Alræk T; Musial F; Steinsbekk A
Complement Ther Med; 2015 Aug; 23(4):535-43. PubMed ID: 26275646
[TBL] [Abstract][Full Text] [Related]
50. Safety analysis of 10 clinical trials and for 13 years after first approval of ioflupane 123I injection (DaTscan).
Grosset DG; Tatsch K; Oertel WH; Tolosa E; Bajaj N; Kupsch A; O'Brien JT; Seibyl J; Walker Z; Sherwin P; Chen C; Grachev ID
J Nucl Med; 2014 Aug; 55(8):1281-7. PubMed ID: 24947061
[TBL] [Abstract][Full Text] [Related]
51. Thoughts, beliefs and concepts concerning infectious childhood diseases of physicians practicing homeopathic, anthroposophic and conventional medicine - a qualitative study.
Mittring-Junghans N; Holmberg C; Witt CM; Teut M
BMC Complement Med Ther; 2021 Jan; 21(1):46. PubMed ID: 33499846
[TBL] [Abstract][Full Text] [Related]
52. Pharmacovigilance in pediatrics.
Bouquet É; Star K; Jonville-Béra AP; Durrieu G
Therapie; 2018 Apr; 73(2):171-180. PubMed ID: 29598957
[TBL] [Abstract][Full Text] [Related]
53. [Management of Acute Gastroenteritis in Children: A Systematic Review of Anthroposophic Therapies].
Schwermer M; Längler A; Fetz K; Ostermann T; Zuzak TJ
Complement Med Res; 2018; 25(5):321-330. PubMed ID: 30041164
[TBL] [Abstract][Full Text] [Related]
54. Should Anthroposophic Medicinal Products Be Regulated in Europe?
Michaux G
Eur J Health Law; 2017 Mar; 24(1):46-66. PubMed ID: 29210253
[TBL] [Abstract][Full Text] [Related]
55. Current concepts on integrative safety assessment of active substances of botanical, mineral or chemical origin in homeopathic medicinal products within the European regulatory framework.
Buchholzer ML; Werner C; Knoess W
Regul Toxicol Pharmacol; 2014 Mar; 68(2):193-200. PubMed ID: 24384395
[TBL] [Abstract][Full Text] [Related]
56. Adverse effects in homeopathy. A systematic review and meta-analysis of observational studies.
Stub T; Kristoffersen AE; Overvåg G; Jong MC; Musial F; Liu J
Explore (NY); 2022; 18(1):114-128. PubMed ID: 33303386
[TBL] [Abstract][Full Text] [Related]
57. Anthroposophic medicine in the treatment of pediatric pseudocroup: A systematic review.
Schwermer M; Längler A; Fetz K; Ostermann T; Zuzak TJ
Complement Ther Med; 2018 Oct; 40():185-190. PubMed ID: 30219446
[TBL] [Abstract][Full Text] [Related]
58. [Systematic review on safety of Salvianolate injection].
Chen ZW; Xie YM; Liao X; Wang GQ
Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(19):3686-3695. PubMed ID: 28925169
[TBL] [Abstract][Full Text] [Related]
59. Pharmacotherapy of elderly patients in everyday anthroposophic medical practice: a prospective, multicenter observational study.
Jeschke E; Ostermann T; Tabali M; Vollmar HC; Kröz M; Bockelbrink A; Witt CM; Willich SN; Matthes H
BMC Geriatr; 2010 Jul; 10():48. PubMed ID: 20663129
[TBL] [Abstract][Full Text] [Related]
60. [Recommendations for problem solving in integrative postgraduate medical training of physicians at anthroposophic hospitals in Germany and Switzerland].
Eberhard S; Weinzirl J; Orlow P; Berger B; Heusser P
Forsch Komplementmed; 2014; 21(5):284-93. PubMed ID: 25427519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
